Immediate Impact
1 by Nobel laureates 15 from Science/Nature 63 standout
Citing Papers
Mechanisms and disease consequences of nonalcoholic fatty liver disease
2021 Standout
Pegbelfermin (BMS-986036), a PEGylated fibroblast growth factor 21 analogue, in patients with non-alcoholic steatohepatitis: a randomised, double-blind, placebo-controlled, phase 2a trial
2018 Standout
Works of Claudio Pagano being referenced
Plasma adiponectin is decreased in nonalcoholic fatty liver disease
2005
Author Peers
| Author | Last Decade | Papers | Cites | ||||
|---|---|---|---|---|---|---|---|
| Claudio Pagano | 1119 | 1130 | 645 | 658 | 75 | 3.1k | |
| Yong Qi | 1470 | 1345 | 1179 | 332 | 82 | 3.4k | |
| Michel Grino | 871 | 698 | 436 | 1490 | 126 | 4.3k | |
| Johan Fernø | 1526 | 685 | 964 | 697 | 79 | 3.4k | |
| Otto Tschritter | 1563 | 1295 | 869 | 932 | 64 | 4.0k | |
| Greg R. Collier | 1028 | 936 | 557 | 286 | 56 | 3.2k | |
| Susan Kralisch | 2365 | 2543 | 767 | 437 | 72 | 4.8k | |
| Carla Roberta de Oliveira Carvalho | 1458 | 616 | 748 | 1116 | 113 | 3.8k | |
| James Brown | 907 | 709 | 385 | 635 | 58 | 3.1k | |
| Irina Kowalska | 1051 | 987 | 313 | 895 | 127 | 3.3k | |
| Anita M. Hennige | 1240 | 734 | 616 | 965 | 77 | 3.7k |
All Works
Login with ORCID to disown or claim papers
Loading papers...